Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Megakaryocytes generate thousands of platelets over their lifespan. More recently, roles in infection and inflammation have been reported. These findings have driven a study of extra-medullary thrombopoiesis, and megakaryocytes have been increasingly reported within the spleen and lung. However, the relative abundance of megakaryocytes in these organs compared to the bone marrow and the scale of their contribution to the platelet pool in steady state remains controversial. We investigated the relative abundance of megakaryocytes in the adult murine bone marrow, spleen, and lung using whole-mount light sheet and quantitative histological imaging, flow cytometry, intravital imaging, and an assessment of scRNA-seq repositories. Flow cytometry revealed significantly higher numbers of hematopoietic stem and progenitor cells and megakaryocytes in the murine bone marrow compared to spleens or perfused lungs. Two-photon intravital and light-sheet microscopy, as well as cryosections confirmed these findings. Moreover, ex-vivo cultured megakaryocytes from the bone marrow subject to static or microfluidic platelet production assays had a higher capacity for proplatelet-formation than MKs from other organs. Analysis of previously published murine and human scRNA-seq datasets revealed that only a marginal fraction of megakaryocyte-like cells can be found within the lung and most likely only marginally contribute to platelet production in the steady state.

Original publication

DOI

10.1182/blood.2023020895

Type

Journal article

Journal

Blood

Publication Date

25/10/2023